Free Trial Information
BioCentury | Apr 21, 2014
Company News

Bio-Techne, PrimeGene deal

...Co. Ltd. subsidiary will acquire PrimeGene in a cash deal slated to close this quarter. PrimeGene...
...its regional manufacturing capabilities and adds over 400 new protein products to its product portfolio. PrimeGene...
...declined to disclose financial terms, and PrimeGene could not be reached. Bio-Techne (NASDAQ:TECH), Minneapolis, Minn. Shanghai PrimeGene Bio-Tech Co....
Read More
BioCentury | Mar 10, 2008
Company News

Arrowhead, PrimeGen deal

PrimeGen and Arrowhead's Unidym Inc. subsidiary partnered to combine Unidym's HIPCO carbon nanotubes with PrimeGen's non-viral cell reprogramming technology. The nanotubes will be used to deliver plasmid DNA and transcription factors to reprogram somatic cells...
Read More
BioCentury | May 7, 2007
Company News

PrimeGen scientific advisory board update

PrimeGen Biotech LLC , Irvine, Calif. Business: Gene/Cell therapy Appointed: Rudolf Jaenisch, professor of biology at the Massachusetts Institute of Technology WIR Staff...
Read More
BioCentury | May 22, 2006
Company News

PrimeGen gene/cell therapy news

PrimeGen Biotech formed PrimeCell Therapeutics LLC, a wholly owned subsidiary that will have rights to PrimeGen Biotech's preclinical PrimeCell non-embryonic stem cell product. PrimeGen Biotech LLC , Irvine, Calif. Business: Gene/Cell therapy WIR Staff...
Read More
BioCentury | Mar 18, 2002
Company News

PrimeGen Biotech Corp. board of directors update

PrimeGen Biotech Corp. , San Diego, Calif. Business: Gene/Cell therapy Appointed: Wayne Irving, CEO at Agilon Products Group Inc. WIR Staff...
Read More
Items per page:
1 - 5 of 5
BioCentury | Apr 21, 2014
Company News

Bio-Techne, PrimeGene deal

...Co. Ltd. subsidiary will acquire PrimeGene in a cash deal slated to close this quarter. PrimeGene...
...its regional manufacturing capabilities and adds over 400 new protein products to its product portfolio. PrimeGene...
...declined to disclose financial terms, and PrimeGene could not be reached. Bio-Techne (NASDAQ:TECH), Minneapolis, Minn. Shanghai PrimeGene Bio-Tech Co....
Read More
BioCentury | Mar 10, 2008
Company News

Arrowhead, PrimeGen deal

PrimeGen and Arrowhead's Unidym Inc. subsidiary partnered to combine Unidym's HIPCO carbon nanotubes with PrimeGen's non-viral cell reprogramming technology. The nanotubes will be used to deliver plasmid DNA and transcription factors to reprogram somatic cells...
Read More
BioCentury | May 7, 2007
Company News

PrimeGen scientific advisory board update

PrimeGen Biotech LLC , Irvine, Calif. Business: Gene/Cell therapy Appointed: Rudolf Jaenisch, professor of biology at the Massachusetts Institute of Technology WIR Staff...
Read More
BioCentury | May 22, 2006
Company News

PrimeGen gene/cell therapy news

PrimeGen Biotech formed PrimeCell Therapeutics LLC, a wholly owned subsidiary that will have rights to PrimeGen Biotech's preclinical PrimeCell non-embryonic stem cell product. PrimeGen Biotech LLC , Irvine, Calif. Business: Gene/Cell therapy WIR Staff...
Read More
BioCentury | Mar 18, 2002
Company News

PrimeGen Biotech Corp. board of directors update

PrimeGen Biotech Corp. , San Diego, Calif. Business: Gene/Cell therapy Appointed: Wayne Irving, CEO at Agilon Products Group Inc. WIR Staff...
Read More
Items per page:
1 - 5 of 5